Skip to content
Other

Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation

W.R. Berkley Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation decreased by 161.7% to -$259M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 1.8%, from -$254.54M to -$259M.

Analysis

StatementIncome Statement
SectionOther
First reportedQ1 2018
Last reportedQ1 2026May 1, 2026
Metric ID: other_cash_cash_equivalents_restricted_cash_and_restrict_8b4577

Historical Data

12 periods
 Q2 '21Q1 '22Q2 '22Q3 '22Q1 '23Q2 '23Q1 '24Q2 '24Q1 '25Q2 '25Q3 '25Q1 '26
Value-$224.71M$546M-$798.24M-$185.85M-$206.99M$581.2M-$194.14M$411.22M-$254.54M$264.32M$419.49M-$259M
QoQ Change+343.0%-246.2%+76.7%-11.4%+380.8%-133.4%+311.8%-161.9%+203.8%+58.7%-161.7%
YoY Change-255.2%-137.9%+172.8%+6.2%-29.2%-31.1%-35.7%-1.8%
Range-$798.24M$581.2M
CAGR+5.3%
Avg YoY Growth-39.0%
Median YoY Growth-30.2%

Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation at Other Companies

Frequently Asked Questions

What is W.R. Berkley's cash, cash equivalent, restricted cash, and restricted cash equivalent, period increase (decrease), including exchange rate effect and discontinued operation?
W.R. Berkley (WRB) reported cash, cash equivalent, restricted cash, and restricted cash equivalent, period increase (decrease), including exchange rate effect and discontinued operation of -$259M in Q1 2026.
How has W.R. Berkley's cash, cash equivalent, restricted cash, and restricted cash equivalent, period increase (decrease), including exchange rate effect and discontinued operation changed year-over-year?
W.R. Berkley's cash, cash equivalent, restricted cash, and restricted cash equivalent, period increase (decrease), including exchange rate effect and discontinued operation decreased by 1.8% year-over-year, from -$254.54M to -$259M.